Filing Details
- Accession Number:
- 0001077183-22-000049
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-03-09 18:02:28
- Reporting Period:
- 2022-03-07
- Accepted Time:
- 2022-03-09 18:02:28
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1077183 | Neogenomics Inc | NEO | Services-Testing Laboratories (8734) | 742897368 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1454941 | William Bonello | 9490 Neogenomics Way Fort Myers FL 33912 | Chief Financial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2022-03-07 | 3,209 | $18.29 | 98,516 | No | 4 | S | Direct | |
Common Stock | Acquisiton | 2022-03-08 | 5,000 | $7.52 | 103,516 | No | 4 | M | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct | |
No | 4 | M | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (Right to Buy) | Disposition | 2022-03-08 | 5,000 | $0.00 | 5,000 | $7.52 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
5,727 | 2022-04-28 | No | 4 | M | Direct |
Reported Derivative Holdings
Sec. Name | Sec. Type | Price | Date | Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (Right to Buy) | $8.03 | 2023-02-26 | 45,370 | 45,370 | Direct | |
Common Stock | Stock Option (Right to Buy) | $19.60 | 2024-03-01 | 41,167 | 41,167 | Direct | |
Common Stock | Stock Option (Right to Buy) | $28.33 | 2027-03-02 | 37,514 | 37,514 | Direct | |
Common Stock | Stock Option (Right to Buy) | $53.17 | 2028-03-02 | 24,619 | 24,619 | Direct | |
Common Stock | Stock Option (Right to Buy) | $21.41 | 2029-03-01 | 99,772 | 99,772 | Direct |
Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
---|---|---|---|
2023-02-26 | 45,370 | 45,370 | Direct |
2024-03-01 | 41,167 | 41,167 | Direct |
2027-03-02 | 37,514 | 37,514 | Direct |
2028-03-02 | 24,619 | 24,619 | Direct |
2029-03-01 | 99,772 | 99,772 | Direct |
Footnotes
- This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
- On April 28, 2017, Mr. Bonello was granted 100,000 stock options. These options vested ratably over the first three anniversary dates of the grant date.
- On February 26, 2018, Mr. Bonello was granted 120,500 stock options. These options vested ratably over the first three anniversary dates of the grant date.
- On March 1, 2019, Mr. Bonello was granted 41,167 stock options. These options vest ratably over the first four anniversary dates of the grant date.
- On March 2, 2020, Mr. Bonello was granted 37,514 stock options. These options vest ratably over the first four anniversary dates of the grant date.
- On March 2, 2021, Mr. Bonello was granted 24,619 stock options. These options vest ratably over the first four anniversary dates of the grant date.
- On March 1, 2022, Mr. Bonello was granted 99,772 stock options. These options vest ratably over the first four anniversary dates of the grant date.